Publications
2022
Shah MA, Udrea AAdrian, Bondarenko I, Mansoor W, Sánchez RGuardeño, Sarosiek T, Bozzarelli S, Schenker M, Gomez-Martin C, Morgan C et al..
2022.
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies.. Cancers (Basel). 14(5)